Cathie Wood’s ARK ETF has made some adjustments recently. One notable change is the addition of 10X Genomics to its portfolio. At the same time, ARK ETF has decided to sell its shares in Rocket Lab. These moves are part of ARK’s strategy to continually assess and optimize its holdings. ARK ETF, under the guidance of Cathie Wood, is known for its active management approach and focus on innovative companies in various sectors. Investors will be watching closely to see how these changes impact ARK’s performance in the coming months.